Abstract:Background Psoriasis is a chronic inflammatory skin disease. Dyslipidemia may be a risk factor of psoriasis. But the causal relationship between psoriasis and blood lipid still remains uncertain. Methods The two data of blood lipid were obtained from UK Biobank (UKBB) and Global Lipid Genetics Consortium Results (GLGC). The primary and secondary database were from large publicly available genome-wide association study (GWAS) with more than 400,000 and 170,000 subjects of European ancestry, respectively. The psoriasis from Finnish biobanks of FinnGen research project for psoriasis, consisting of 6,995 cases and 299,128 controls. The single-variable Mendelian randomization (SVMR) and multivariable Mendelian randomization (MVMR) were used to assess the total and direct effects of blood lipid on psoriasis risk. Results SVMR estimates in primary data of blood lipid showed low-density lipoprotein cholesterol (LDL-C) (odds ratio (OR): 1.11, 95%, confidence interval (CI): 0.99−1.25, p = 0.082 in stage 1; OR: 1.15, 95% CI: 1.05−1.26, p = 0.002 in stage 2; OR: 1.15, 95% CI: 1.04−1.26, p = 0.006 in stage 3) and triglycerides (TG) (OR: 1.22, 95% CI: 1.10−1.35, p = 1.17E-04 in stage 1; OR: 1.15, 95% CI: 1.06−1.24, p = 0.001 in stage 2; OR: 1.14, 95% CI: 1.05−1.24, p = 0.002 in stage 3) had a highly robust causal relationship on the risk of psoriasis. However, there were no robust causal associations between HDL-C and psoriasis. The SVMR results in secondary data of blood lipid were consistent with the primary data. Reverse MR analysis showed a causal association between psoriasis and LDL-C (beta: -0.009, 95% CI: -0.016− -0.002, p = 0.009) and HDL-C (beta: -0.011, 95% CI: -0.021− -0.002, p = 0.016). The reverse causation analyses results between psoriasis and TG did not reach significance. In MVMR of primary data of blood lipid, the LDL-C (OR: 1.05, 95% CI: 0.99–1.25, p = 0.396 in stage 1; OR: 1.07, 95% CI: 1.01–1.14, p = 0.017 in stage 2; OR: 1.08, 95% CI: 1.02–1.15, p = 0.012 in stage 3) and TG (OR: 1.11, 95% CI: 1.01–1.22, p = 0.036 in stage 1; OR: 1.09, 95% CI: 1.03–1.15, p = 0.002 in stage 2; OR: 1.07, 95% CI: 1.01–1.13 p = 0.015 in stage 3) positively correlated with psoriasis, and there had no correlation between HDL-C and psoriasis. The results of the secondary analysis were consistent with the results of primary analysis. Conclusions Mendelian randomization (MR) findings provide genetic evidence for causal link between psoriasis and blood lipid. It may be meaningful to monitor and control blood lipid level for a management of psoriasis patients in clinic.

Blood glucose and lipids are associated with sarcoidosis: findings from observational and mendelian randomization studies

Genetic association of lipids and lipid lowering drug target genes with sarcoidosis

Genetically predicted serum uric acid levels and the risk of coronary artery disease in patients with diabetes: A Mendelian randomization study

The causal relationship between sarcoidosis and autoimmune diseases: a bidirectional Mendelian randomization study in FinnGen

Causal association of inflammatory bowel disease with sarcoidosis and the mediating role of primary biliary cholangitis

Genetic Correlations and Causal Relationships Between Cardio-Metabolic Traits and Sepsis

The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis

Casual effects of telomere length on sarcoidosis: a bidirectional Mendelian randomization analysis

Role of triglyceride-glucose index in metabolic assessment of sarcoidosis patients

Exome Sequencing Reveals Genetic Variability and Identifies Chronic Prognostic Loci in Chinese Sarcoidosis Patients

Causal associations between autoimmune diseases and sarcopenia-related traits: a bi-directional Mendelian randomization study

Causal influence of celiac disease on the risk of sarcoidosis: A Mendelian randomization study

Aberrant Lipid Metabolism in Macrophages Is Associated with Granuloma Formation in Sarcoidosis

Association between immune cells, inflammatory cytokines, and sarcopenia: Insights from a Mendelian randomization analysis

Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study

Characterizing the Causal Associations Between Blood Metabolites, Schizophrenia and Neurocognitive Traits Using a Mendelian Randomization Study

Appraising the Effects of Metabolic Traits on the Risk of Glaucoma: A Mendelian Randomization Study

Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization study

Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis

Genetic causality and metabolite pathway identifying the relationship of blood metabolites and psoriasis

Association Between Autoimmune Diseases and Sarcopenia: A Two-Sample Mendelian Randomization Study